Skip to main content
MGI TECH CO., LTD. logo

MGI TECH CO., LTD. — Investor Relations & Filings

Ticker · 688114 ISIN · CNE100005PC8 LEI · 300300BUXXDJ2MITLZ69 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 572 across all filing types
Latest filing 2026-05-21 Legal Proceedings Report
Country CN China
Listing Shanghai Stock Exchange 688114

About MGI TECH CO., LTD.

https://www.mgi-tech.com/

MGI Tech Co., Ltd. specializes in the development of advanced sequencing instruments, reagents, and laboratory automation systems. The company provides high-throughput genetic sequencing solutions powered by its proprietary DNBSEQ™ technology, which utilizes DNA Nanoballs to enhance accuracy and efficiency. MGI’s product portfolio includes a range of genetic sequencers, automated sample preparation systems, and integrated bioinformatics platforms designed for clinical research, healthcare, and agricultural applications. By offering scalable and cost-effective genomic tools, MGI supports large-scale population genomics projects and precision medicine initiatives. The company serves a diverse clientele, including academic institutions, pharmaceutical developers, and diagnostic laboratories, aiming to advance the accessibility of genomic information through technological innovation.

Recent filings

Filing Released Lang Actions
关于公司及子公司涉及诉讼的公告
Legal Proceedings Report Classification · 91% confidence The document is an announcement by Shenzhen Huada Zhizao Technology Co., Ltd. regarding ongoing litigation involving the company and its subsidiaries, detailing case background, parties, claims, and potential impacts. It is clearly an update on legal proceedings rather than a financial report, management change, or general regulatory filing. This matches the definition of a Legal Proceedings Report (Code: LTR).
2026-05-21 Chinese
关于召开2025年度暨2026年第一季度业绩说明会的公告
Regulatory Filings Classification · 80% confidence The document is an announcement (公告) of the company’s upcoming 2025 annual and 2026 Q1 “performance explanation” investor meeting (业绩说明会). It provides meeting time, location, web participation details, and contact information, but contains no actual financial statements, earnings highlights, or presentation materials themselves. It is not the report itself, nor a dividend notice, nor an earnings release, but a general regulatory announcement of an investor event. Therefore it falls under the fallback category “Regulatory Filings” (RNS).
2026-05-18 Chinese
中信证券股份有限公司关于深圳华大智造科技股份有限公司持续督导保荐总结报告书
Regulatory Filings Classification · 85% confidence The document is a “持续督导保荐总结报告书” (continuous supervision sponsor summary report) filed by the IPO sponsor (中信证券) regarding its ongoing regulatory and compliance oversight of a listed company. It is not a financial statement or earnings release, nor an announcement of a board change, dividend, share issue, or any other specific category. It is a regulatory compliance document and thus falls into the fallback “Regulatory Filings” category (RNS).
2026-05-13 Chinese
中信证券股份有限公司关于深圳华大智造科技股份有限公司2025年持续督导工作现场检查结果及提请公司注意事项
Report Publication Announcement Classification · 78% confidence The document is a brief sponsor’s cover letter summarizing the results of a 2025 onsite inspection and refers to an attached detailed report. It is under 5000 characters and merely announces publication of the actual report (the inspection report is in an attachment). This matches the “Report Publication Announcement” pattern rather than being the full report itself.
2026-05-12 Chinese
关于召开2025年年度股东会的通知
Regulatory Filings
2026-05-06 Chinese
2025年度会计师事务所履职情况评估报告
Regulatory Filings
2026-04-24 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.